Detalles de la búsqueda
1.
Long-term immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B) compared with HepB-Eng (Engerix-B) in adults with chronic kidney disease.
Vaccine
; 41(20): 3224-3232, 2023 05 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37085451
2.
Immunogenicity and safety of a booster dose of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) compared with HepB-Eng (Engerix-B®) and HepB-AS04 (Fendrix®) in adults receiving hemodialysis who previously received hepatitis B vaccination and are not seroprotected: Results of a randomized, multicenter phase 3 study.
Hum Vaccin Immunother
; 18(6): 2136912, 2022 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36269938
3.
Comparative cost-effectiveness of a 2-dose versus 3-dose vaccine for hepatitis B prevention in selected adult populations.
Vaccine
; 39(33): 4733-4741, 2021 07 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34030898
4.
Considerations for estimating real-world outcomes and value in vaccination: A case study with adult hepatitis B virus vaccination.
Vaccine
; 39(39): 5666-5672, 2021 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34404556
5.
An open-label, single-arm study evaluating the immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) in adults receiving hemodialysis.
Vaccine
; 39(25): 3346-3352, 2021 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34001345
6.
Immunogenicity and safety of a 2-dose hepatitis B vaccine, HBsAg/CpG 1018, in persons with diabetes mellitus aged 60-70â¯years.
Vaccine
; 37(39): 5854-5861, 2019 09 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-31431412
7.
Estimation of HIV incidence in the United States.
JAMA
; 300(5): 520-9, 2008 Aug 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-18677024
8.
Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults.
Vaccine
; 36(5): 668-674, 2018 01 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-29289383
9.
SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study.
Cancer Discov
; 8(10): 1250-1257, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30154193
10.
Implementing HIV screening.
Clin Infect Dis
; 45 Suppl 4: S226-31, 2007 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18190291
11.
HIV testing: rationale for changing recommendations.
Top HIV Med
; 15(1): 6-10, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17406078
12.
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.
MMWR Recomm Rep
; 55(RR-16): 1-33; quiz CE1-4, 2006 Dec 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-17159833
13.
Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings.
MMWR Recomm Rep
; 55(RR-14): 1-17; quiz CE1-4, 2006 Sep 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-16988643
14.
Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA.
AIDS
; 20(10): 1447-50, 2006 Jun 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-16791020
15.
Immunogenicity of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in subpopulations of healthy adults 18-70 years of age.
Vaccine
; 33(31): 3614-8, 2015 Jul 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-26067185
16.
Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in patients with chronic kidney disease and type 2 diabetes mellitus.
Vaccine
; 33(7): 833-7, 2015 Feb 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-25576215
17.
Classification of transmission risk in the national HIV/AIDS surveillance system.
Public Health Rep
; 118(5): 400-7, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-12941852
18.
Advancing HIV prevention demonstration projects: new strategies for a changing epidemic.
Public Health Rep
; 123 Suppl 3: 5-15, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-19172707
19.
Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared to a licensed hepatitis B vaccine in healthy adults 40-70 years of age.
Vaccine
; 31(46): 5300-5, 2013 Nov 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-23727002
20.
Immunogenicity and safety of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in patients with chronic kidney disease.
Vaccine
; 31(46): 5306-13, 2013 Nov 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-23727422